Clinical Trial Results

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2